Our Leadership

Jonathan Barker is Professor of Medical Dermatology and Academic Head of Department at St John's Institute of Dermatology, King's College London. He is Co-Director of the Skin Therapy Research Unit and the Psoriasis Service at the Institute, a large tertiary referral service for patients with severe disease. His research interests extend from genetic discovery through to clinical outcome measurement. As such he is a key investigator in international consortia aiming to map psoriasis susceptibility genes and heads the International Psoriasis Council (IPC) exome consortium. He is deputy director of a multi-centre MRC stratified medicine programme in psoriasis outcomes to biologic therapy (PSORT) and heads its genetics working group. Professor Barker has published over 200 peer-reviewed papers, authored and edited several books including the new edition of the 'Rook Book'. Highly cited publications include those in Nature Genetics, American Journal of Human Genetics and New England Journal of Medicine. He sits on the editorials boards of several dermatology journals. He is past President of the European Dermatology Forum. Currently he is President of IPC.

Last Updated: Oct 04, 2018

Dr. Leonardi is clinical professor of dermatology at St. Louis University School of Medicine in St. Louis, Mo., where he also has a private practice. He received his medical degree from the University of Miami School of Medicine in Florida, and completed an internship in pediatrics and residency in dermatology at the University of Miami/Jackson Memorial Hospital. Dr. Leonardi is certified by the American Board of Dermatology. He is a fellow of the American Academy of Dermatology and a member of the Noah Worcester Dermatological Society. He is a past member of the medical board of the National Psoriasis Foundation. Dr. Leonardi has extensive experience using new biologics in the treatment of psoriasis. He has been a speaker at national, regional and state venues, and serves on the advisory boards of several pharmaceutical companies. He has been involved in more than 150 clinical trials and has published more than 150 original articles and abstracts.

Last Updated: May 08, 2012

Bruce E. Strober, MD, PhD, is an Assistant Clinical Professor at Yale University, Department of Dermatology. He received his medical and graduate degrees from Columbia University College of Physicians and Surgeons and completed his postgraduate training in dermatology at New York University. Dr. Strober is board certified by the American Board of Dermatology, a fellow of the American Academy of Dermatology, and a past member of the medical board of the National Psoriasis Foundation. Dr. Strober has authored numerous journal articles and book chapters. He has also spoken extensively to both physician and patient audiences in the field of dermatology. Dr. Strober has authored numerous journal articles and has spoken extensively to both physician and patient audiences in the field of psoriasis.

Last Updated: Aug 01, 2018

Ms. Langan brings over 20 years of non-profit management experience in the areas of program development, event management, public relations, marketing and communications, and fundraising. She has served in senior leadership positions with two national non-profit organizations and served as Executive Director of Volunteer San Diego. Prior to joining IPC, she served in various capacities with the National Psoriasis Foundation including Sr. Director of Education and Outreach where she was responsible for developing and managing education programs for patients and medical professionals and as Director of Corporate Relations where she raised support for the organization and worked closely with industry to develop outreach programs. Ms. Langan brings to IPC a diverse set of skills, an entrepreneurial spirit and a passion for improving the lives of those living with psoriasis. She earned her Bachelor's in Business Administration from Concordia University in Portland, Oregon.

Last Updated: Dec 28, 2015

Professor Bachelez is professor at the Department of Dermatology of the Saint-Louis University Hospital in Paris, France. Since 2004, Professor Bachelez has been full professor of clinical dermatology at the Université Paris-Diderot/Université de Paris, where he received his Ph.D. in immunology in 1999. Professor Bachelez’s clinical and scientific research focuses on immunogenetics of inflammatory skin diseases at the Institut National de la Santé et de la Recherche Médicale (INSERM) at the Imagine Institute in Necker Hospital. His areas of scientific interest include molecular mechanisms of psoriasis and psoriasis-related diseases, and other immune-mediated and inflammatory skin diseases. Professor Bachelez has received several scientific awards, including the Robert Degos award. He is a member of several national and international scientific societies, including the European Academy of Dermatology and Venereology and the European Dermatology Forum (EDF). He is a board member of the International Psoriasis Council, and general secretary-Treasurer-elect of the European Society for Dermatological Research (ESDR).
Professor Bachelez has published more than 230 manuscripts in peer-reviewed journals, including the New England Journal of Medicine, The Lancet, Journal of Clinical Investigation, and Arthritis and Rheumatism as leading author.

Last Updated: Jul 01, 2019

Claudia de la Cruz received her medical degree from Universidad de Chile, Sede Oriente, Hospital de Salvador, Hospital, U. Chile, Chile. She received her dermatology training at Universidad de Chile, Hospital Jose Joaquinaguirre . She maintains academic affiliations with Universidad Católica de Chile as an Assistant Professor in Dermatology. She is also very active in the Chilean Society of Dermatology and is the coordinator of the psoriasis group and is a member of the National Ministry of Health Committee for Psoriasis Disease. Dr. de la Cruz has also published several papers on psoriasis and has presented at both national and international congresses on psoriasis and related issues. She is fluent in Spanish and English.

Last Updated: May 07, 2019

Professor Christopher Griffiths is Director of the Manchester Centre for Dermatology Research and Head of the Dermatology Theme of the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre. He gained a 1st Class Hons BSc in Anatomy from St Thomas’ Hospital Medical School, London in 1976 and qualified in Medicine MB BS in 1979. Following junior hospital posts in South London he trained in Dermatology at St Mary’s Hospital, London (1983-87) where he was a Wellcome Trust Clinical Research Training Fellow (1985-87). In 1987 he took up a research fellowship in Dermatology at the University of Michigan, USA, and was appointed to Assistant Professorship on Faculty 1989-93. He was appointed to the Foundation Chair in Dermatology at the University of Manchester in 1994 and is an Honorary Consultant Dermatologist at Salford Royal NHS Foundation Trust.   Professor Griffiths has received several medals and honors for his work in psoriasis, most recently, he was appointed an Officer of the Order of the British Empire (OBE), for services to dermatology, in the Queen’s 2018 New Year’s Honours. He is one of the co-founders of the International Psoriasis Council and past-President. He has also been President of the British Association of Dermatologists European Dermatology Forum and British Society for Investigative Dermatology.

Last Updated: Jan 25, 2018

Mr Holland was a member of the Bush Administration until April 2006, serving as United States Executive Director of the World Bank. From 1993 to 1999, he served in various positions, including General Counsel and Chief Executive Officer of Triton Energy Ltd, a New York Stock Exchange listed exploration company that was sold to Amerada Hess. He is a former board member of NYSE listed Pier 1 Imports Inc., Massey Energy Inc. and Ivanhoe Mines Ltd. Mr Holland is currently a director of Primexx Operating Corporation, a privately owned oil and gas producer operating in the USA. From 1977 to 1994 he practiced law with the Texas law firm, Jackson Walker LLP, and is a graduate of Stanford University and the University of Texas Law School. Mr. Holland is a member of IPC's Finance Committee.

Last Updated: Dec 29, 2014

Professor Iversen, an IPC councilor since 2009, is professor in dermatology at the University of Aarhus, Denmark, where he also teaches dermato-venereology. He received his clinical education and obtained a doctoral degree from the same university. Professor Iversen's main research interests are psoriasis and cutaneous T-cell lymphoma. Most of his research activities are related to signal transduction and immunology. Professor Iversen has served as a guest researcher and has been a speaker at international conferences in Asia, Europe and the United States. He is the author or co-author of 155 articles and book chapters and the holder of one patent. He serves as a section editor for Acta Dermato-Venereologica and on the editorial board of Experimental Dermatology. His writings have appeared in several scientific journals including Nature Immunology, PNAS, the Journal of Immunology, and the Journal of Investigative Dermatology. Professor Iversen has chaired IPC's Topical Therapy Working Group since 2013.

Last Updated: Jan 25, 2018

Alexa Boer Kimball, MD, MPH, is the Vice President for Practice Improvement at the Massachusetts General Physician Organization and serves as the Vice Chair of the Department of Dermatology and Director of the Clinical Unit for Research Trials and Outcomes in Skin based at the Massachusetts General Hospital in Boston. Professor Kimball was appointed Professor of Dermatology at Harvard Medical School September 1, 2013 marking the first time a female dermatologist has achieved this distinction. Prof. Kimball received her medical degree from the Yale University School of Medicine after obtaining bachelor's degrees in molecular biology and public and international affairs from Princeton University. She completed her residency in dermatology at the Stanford University Medical Center and a clinical research fellowship in dermatology at the National Institutes of Health in Bethesda, Maryland, as she concurrently obtained an MPH from the Johns Hopkins School of Public Health.

Last Updated: Oct 05, 2018

Dr. Menter is Chairman of the Division of Dermatology and Director of the Dermatology Residency program for Baylor University Medical Center, and Clinical Professor of Dermatology at the University of Texas Southwestern Medical School, both in Dallas. After obtaining his medical degree from the University of Witwatersrand in Johannesburg, South Africa, Professor Menter completed his residency in dermatology at the University of Pretoria in South Africa and fellowships at Guy's Hospital in London and St. John's Hospital for Diseases of the Skin in London, as well as the University of Texas Southwestern Medical School. Dr. Menter is board-certified in dermatology. He is involved in multiple clinical, investigative and drug research studies, particularly those relating to psoriasis. In August 2004, he founded the International Psoriasis Council (IPC).

Last Updated: Jan 02, 2014

Dr. Lluis Puig is Director of the Dermatology Department at Hospital de la Santa Creu i Sant Pau (HSCSP) in Barcelona and Prof. of Dermatology at Autonomous University of Barcelona (UAB) Medical School. Prof. Puig received a medical degree (Hon) at the Medical Faculty of UAB and was a recipient of the Special Curricular Award upon graduating in 1982. In 1987 he completed his residency training in Dermatology at HSCSP Department of Dermatology and received the Spanish Board Certificate in Medical-Surgical Dermatology and Venereology. In 1991 he completed his PhD on pharmacologic modulation of lipid inflammatory mediators in psoriasis at UAB, and was recipient to the Special Award for doctoral theses during that year. Prof. Puig worked as a Senior Research Associate at the Institute of Biomedical Research. His body of work includes nine research projects, on a wide variety of subjects related to the pathophysiology of psoriasis, experimental pharmacology and inmunohistopathology, among others. Over the past ten years, Prof. Puig has focused his clinical research on treatment of psoriasis with biological agents and has participated in 21 clinical trials to date. The results of his research have been presented at both national and international meetings, have been the subject of more than 250 papers, including review articles and continuous medical education papers, and 10 international book chapters. Prof. Puig is an Editorial Board Member of Piel, Actas Dermosifiliogrficas, Medicina Cutnea Latinoamericana, Medicina Clnica, among other journals. He served as a reviewer for a wide number of scientific publications including the Archives of Dermatology, the British Journal of Dermatology and the Journal of the European Academy of Dermatology and is a founding member of several working groups of the Spanish Academy of Dermatology and Venereology. He is a member of the EADV, AAD, ESDR, ASDP, ISDP, GRAPPA, and other societies. He is a board member of the International Psoriasis Council.

Last Updated: Jan 26, 2018

Romiti obtained his medical degree from the University of São Paulo's Faculty of Medicine in 1992. Three years later, he completed his residency in the university's dermatology department. He was a fellow at the Ludwig-Maximilians-Universität, Munich, Germany, and was a visiting doctor at the Mayo Clinic, Jacksonville, Fla., and the Medical College of Wisconsin, Milwaukee, Wis., in the U.S. Professor Romiti has authored or co-authored numerous papers published in national and international dermatology journals. Since 2005, he has been a member of the evaluation board for the dermatology faculty of the Faculty of 1000 Medicine. In addition to the IPC, Professor Romiti is a member of the Sociedade Latinoamericana de Psoríase (SOLAPSO). He is fluent in German, English and Spanish.

Last Updated: Jan 25, 2018